Karyopharm Therapeutics Stock Volatility
| KPTI Stock | USD 0.88 0.04 4.76% |
Karyopharm Therapeutics appears to be very risky, given 3 months investment horizon. Karyopharm Therapeutics has Sharpe Ratio of 0.0646, which conveys that the firm had a 0.0646% return per unit of risk over the last 3 months. We have found thirty technical indicators for Karyopharm Therapeutics, which you can use to evaluate the volatility of the firm. Please exercise Karyopharm Therapeutics' Risk Adjusted Performance of 0.043, downside deviation of 4.23, and Mean Deviation of 3.38 to check out if our risk estimates are consistent with your expectations. Key indicators related to Karyopharm Therapeutics' volatility include:
300 Days Market Risk | Chance Of Distress | 300 Days Economic Sensitivity |
Karyopharm Therapeutics Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Karyopharm daily returns, and it is calculated using variance and standard deviation. We also use Karyopharm's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Karyopharm Therapeutics volatility.
Karyopharm |
Karyopharm Therapeutics Stock Volatility Analysis
Volatility refers to the frequency at which Karyopharm Therapeutics stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Karyopharm Therapeutics' price changes. Investors will then calculate the volatility of Karyopharm Therapeutics' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Karyopharm Therapeutics' volatility:
Historical Volatility
This type of stock volatility measures Karyopharm Therapeutics' fluctuations based on previous trends. It's commonly used to predict Karyopharm Therapeutics' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Karyopharm Therapeutics' current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Karyopharm Therapeutics' to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Karyopharm Therapeutics Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Karyopharm Therapeutics Projected Return Density Against Market
Given the investment horizon of 90 days the stock has the beta coefficient of 1.0047 . This indicates Karyopharm Therapeutics market returns are responsive to returns on the market. As the market goes up or down, Karyopharm Therapeutics is expected to follow.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Karyopharm Therapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Karyopharm Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Karyopharm stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Karyopharm Therapeutics has an alpha of 0.1026, implying that it can generate a 0.1 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Predicted Return Density |
| Returns |
What Drives a Karyopharm Therapeutics Price Volatility?
Several factors can influence a stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Karyopharm Therapeutics Stock Risk Measures
Given the investment horizon of 90 days the coefficient of variation of Karyopharm Therapeutics is 1548.47. The daily returns are distributed with a variance of 27.4 and standard deviation of 5.23. The mean deviation of Karyopharm Therapeutics is currently at 3.41. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.76
α | Alpha over Dow Jones | 0.10 | |
β | Beta against Dow Jones | 1.00 | |
σ | Overall volatility | 5.23 | |
Ir | Information ratio | 0.02 |
Karyopharm Therapeutics Stock Return Volatility
Karyopharm Therapeutics historical daily return volatility represents how much of Karyopharm Therapeutics stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm inherits 5.2343% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7716% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About Karyopharm Therapeutics Volatility
Volatility is a rate at which the price of Karyopharm Therapeutics or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Karyopharm Therapeutics may increase or decrease. In other words, similar to Karyopharm's beta indicator, it measures the risk of Karyopharm Therapeutics and helps estimate the fluctuations that may happen in a short period of time. So if prices of Karyopharm Therapeutics fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.| Last Reported | Projected for Next Year | ||
| Market Cap | 1.1 B | 1.1 B |
Karyopharm Therapeutics' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Karyopharm Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Karyopharm Therapeutics' price varies over time.
3 ways to utilize Karyopharm Therapeutics' volatility to invest better
Higher Karyopharm Therapeutics' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Karyopharm Therapeutics stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Karyopharm Therapeutics stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Karyopharm Therapeutics investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Karyopharm Therapeutics' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Karyopharm Therapeutics' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Karyopharm Therapeutics Investment Opportunity
Karyopharm Therapeutics has a volatility of 5.23 and is 6.79 times more volatile than Dow Jones Industrial. 46 percent of all equities and portfolios are less risky than Karyopharm Therapeutics. You can use Karyopharm Therapeutics to enhance the returns of your portfolios. The stock experiences a very speculative upward sentiment. Check odds of Karyopharm Therapeutics to be traded at $1.1 in 90 days.Average diversification
The correlation between Karyopharm Therapeutics and DJI is 0.15 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Karyopharm Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Karyopharm Therapeutics Additional Risk Indicators
The analysis of Karyopharm Therapeutics' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Karyopharm Therapeutics' investment and either accepting that risk or mitigating it. Along with some common measures of Karyopharm Therapeutics stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | 0.043 | |||
| Market Risk Adjusted Performance | 0.2325 | |||
| Mean Deviation | 3.38 | |||
| Semi Deviation | 3.48 | |||
| Downside Deviation | 4.23 | |||
| Coefficient Of Variation | 2217.85 | |||
| Standard Deviation | 5.18 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Karyopharm Therapeutics Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Karyopharm Therapeutics as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Karyopharm Therapeutics' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Karyopharm Therapeutics' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Karyopharm Therapeutics.
Complementary Tools for Karyopharm Stock analysis
When running Karyopharm Therapeutics' price analysis, check to measure Karyopharm Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Karyopharm Therapeutics is operating at the current time. Most of Karyopharm Therapeutics' value examination focuses on studying past and present price action to predict the probability of Karyopharm Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Karyopharm Therapeutics' price. Additionally, you may evaluate how the addition of Karyopharm Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |